Relief Therapeutics Holding AG (RLFTF)

USD 4.9

(0.0%)

Long Term Debt Summary of Relief Therapeutics Holding AG

  • Relief Therapeutics Holding AG's latest annual long term debt in 2023 was 9000.00 CHF , down -99.6% from previous year.
  • Relief Therapeutics Holding AG's latest quarterly long term debt in 2024 Q1 was - CHF , down -100.0% from previous quarter.
  • Relief Therapeutics Holding AG reported annual long term debt of 2.24 Million CHF in 2022, down -13.14% from previous year.
  • Relief Therapeutics Holding AG reported annual long term debt of 2.58 Million CHF in 2021, down 0.0% from previous year.
  • Relief Therapeutics Holding AG reported quarterly long term debt of - CHF for 2024 Q2, down 0.0% from previous quarter.
  • Relief Therapeutics Holding AG reported quarterly long term debt of 2.34 Million CHF for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Relief Therapeutics Holding AG (2023 - 2007)

Historical Annual Long Term Debt of Relief Therapeutics Holding AG (2023 - 2007)

Year Long Term Debt Long Term Debt Growth
2023 9000.00 CHF -99.6%
2022 2.24 Million CHF -13.14%
2021 2.58 Million CHF 0.0%
2020 - CHF 0.0%
2019 - CHF -100.0%
2018 4.31 Million CHF 0.0%
2017 - CHF 0.0%
2016 - CHF -100.0%
2015 2.06 Million CHF 877.89%
2014 211.62 Thousand CHF -93.45%
2013 3.23 Million CHF 3221.62%
2012 97.25 Thousand CHF -23.56%
2011 127.22 Thousand CHF -52.8%
2010 269.55 Thousand CHF 61.05%
2009 167.36 Thousand CHF -49.17%
2008 329.25 Thousand CHF -90.67%
2007 3.53 Million CHF 0.0%

Peer Long Term Debt Comparison of Relief Therapeutics Holding AG

Name Long Term Debt Long Term Debt Difference
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 99.957%
Evofem Biosciences, Inc. 8000.00 USD -12.5%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 99.487%
Mesoblast Limited 100.29 Million USD 99.991%
Propanc Biopharma, Inc. 58.64 Thousand USD 84.653%
Genus plc 228.2 Million USD 99.996%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Marizyme, Inc. 667.12 Thousand USD 98.651%
ContraFect Corporation 2.21 Million USD 99.593%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 99.358%
Intellipharmaceutics International Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 5.42 Million USD 99.834%
MultiCell Technologies, Inc. 36.43 USD -24604.914%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 99.984%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 99.596%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 99.267%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.995%
Oncotelic Therapeutics, Inc. 1.89 Million USD 99.526%
Skye Bioscience, Inc. 171.23 Thousand USD 94.744%
Therapeutic Solutions International, Inc. 5512.00 USD -63.28%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
IMV Inc. 27.39 Million USD 99.967%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD 97.205%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 100.0%
Halberd Corporation 150 Thousand USD 94.0%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 300 Thousand USD 97.0%
Nuo Therapeutics, Inc. 164.2 Thousand USD 94.519%
argenx SE 15.35 Million USD 99.941%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 99.956%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -101.975%
Genscript Biotech Corporation 287.12 Million USD 99.997%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD 92.874%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 96.075%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 98.377%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD 64.425%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 99.891%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD 96.612%
ONE Bio Corp. 592.19 Thousand USD 98.48%
Reve Technologies, Inc. 1064.00 USD -745.865%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD 93.985%
Regen BioPharma, Inc. 149.61 Thousand USD 93.985%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD 96.082%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD 93.617%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD 88.75%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 99.885%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD 97.561%
International Stem Cell Corporation 445 Thousand USD 97.978%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 99.89%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD 98.031%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 99.225%
PureTech Health plc 18.25 Million USD 99.951%
Coeptis Therapeutics, Inc. 150 Thousand USD 94.0%
IXICO plc 275 Thousand USD 96.727%
IntelGenx Technologies Corp. 11.83 Million USD 99.924%
Gelesis Holdings, Inc. 26.3 Million USD 99.966%
CSL Limited 11.23 Billion USD 100.0%
Cellectis S.A. 36.21 Million USD 99.975%